Año: 2003
Journal Impact Factor (JIF): 1.1840
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 124/185 | Q3 | T3 | D7 |
| ONCOLOGY | SCIE | 94/120 | Q4 | T3 | D8 |
Año: 2017
Journal Citation Indicator (JCI): 0,330
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 233/290 | Q4 | T3 | D9 | 19,83 |
| PHARMACOLOGY & PHARMACY | 271/336 | Q4 | T3 | D9 | 19,49 |
Año:
2011
CiteScore:
3,400
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Drug Discovery | 50/140 | Q2 | T2 | D4 |
| General Medicine | 1158/3161 | Q2 | T2 | D4 |
| Infectious Diseases | 85/220 | Q2 | T2 | D4 |
| Oncology | 106/273 | Q2 | T2 | D4 |
| Pharmacology (medical) | 84/214 | Q2 | T2 | D4 |
| Pharmacology | 128/304 | Q2 | T2 | D5 |
SJR año:
2003
Factor de Impacto:
0,382
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Medicine (miscellaneous) | 878/2795 | Q2 | T1 | D4 |
| Pharmacology (medical) | 76/180 | Q2 | T2 | D5 |
| Infectious Diseases | 84/154 | Q3 | T2 | D6 |
| Oncology | 107/203 | Q3 | T2 | D6 |
| Pharmacology | 153/293 | Q3 | T2 | D6 |
| Drug Discovery | 59/91 | Q3 | T2 | D7 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Ballesta, Sofía | Universidad de Sevilla (Spain) |
| 2 | Universidad de Sevilla (Spain) | |
| 3 | García, Isabel | Universidad de Sevilla (Spain) |
| 4 | Perea, Evelio J. | Universidad de Sevilla (Spain) |